Brenner, I. R., Flanagan, C. F., Penazzato, M., Webb, K. A., Horsfall, S. B., Hyle, E. P., Abrams, E., Bacha, J., Neilan, A. M., Collins, I. J., Desmonde, S., Crichton, S., Davies, M.-A., Freedberg, K. A., & Ciaranello, A. L. (2024). Cost-effectiveness of viral load testing for transitioning antiretroviral therapy-experienced children to dolutegravir in South Africa: a modelling analysis. The Lancet Global Health, 12(12), e2068–e2079. https://doi.org/10.1016/s2214-109x(24)00381-4

Abrams, E. J., Jao, J., Madlala, H. P., Zerbe, A., Catalano, P., Gerschenson, M., Goedecke, J. H., Gomba, Y., Josefson, J., Kurland, I. J., Legbedze, J., McComsey, G. A., Matyesini, S., Mukonda, E., Robinson, D., & Myer, L. (2024). An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol. PLOS ONE, 19(8), e0307296. https://doi.org/10.1371/journal.pone.0307296